UV Infection Control Devices Market Size, Share, Competitive Landscape and Trend Analysis Report 2030

UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have handles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a standard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.

According to the report, the global UV infection control devices industry was pegged at $317.4 million in 2018, and is expected to hit $524.8 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.

Drivers, restraints, and opportunities-

Rise in government focus on infection control programs, increase in the prevalence of hospital-acquired infections, and rise in adoption of technology advanced UV equipment fuel the growth of the global UV infection control market. On the other hand, high cost of UV infection control devices and stringent government regulation restrain the growth to some extent. However, high growth prospects in emerging markets is expected to create lucrative opportunities in the near future.

Request Sample Report at https://www.alliedmarketresearch.com/request-sample/6472

The mobile segment to lead the trail by 2027-

Based on type, the mobile segment contributed to more than two-fifths of the global UV infection control market share in 2018. The segment is expected to rule the roost till 2026. In addition, the same segment would cite the fastest CAGR of 7.3% throughout the forecast period. This is attributable to surge in the prevalence of hospital-acquired infections across the globe and benefits associated with mobile UV infection control devices.

The end user segment to dominate during the estimated period-

Based on end user, the hospital segment held the major share in 2018, generating nearly half of the global UV infection control market. The segment is anticipated to maintain its dominance throughout the forecast period. Moreover, the same segment would showcase the fastest CAGR of 6.8% during the study period. This is attributed to the fact that hospitals receive different types of patients that require surgeries, which leads to increase the adoption of UV infection control devices and therefore drives the growth of the segment.

North America to retain its dominance in terms of revenue-

Based on geography, North America accounted for more than two-fifths of the global UV infection control market revenue in 2026, and is projected to maintain the lion's share from 2019 to 2026. The region is anticipated to maintain its dominance throughout the forecast period. This is attributed to the rise in the number of cases of HAIs and presence of key players lead to easy availability of these devices in this region. On the other hand, the region across Asia-Pacific is expected to manifest the fastest CAGR of 8.1% from 2020 to 2027. This is due to the improvements in health standards, surge in disposable incomes, and advancements in technology for the development of new UV infection control devices in this region.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6472

Frontrunners in the industry-

CVS Health Corporation
DocMorris
Express Scripts Holding Company
Giant Eagle Inc.
Optum Rx Inc.
Rowlands Pharmacy
The Kroger Co.
Walgreen Co.
Walmart Stores Inc.
Apollo Pharmacy.

Contact

David Correa

1209 Orange Street,

Corporation Trust Center,

Wilmington, New Castle,

Delaware 19801 USA.

Toll Free: +1-800-792-5285

Int'l: +1-503-894-6022

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1-855-550-5975

help@alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.